Latest food-allergy stories and video coverage scraped from trusted sources — including SnackSafely.com, Allergic Living, the Harvard Nadeau Lab, NIAID, and broadcast & new-media reports from news stations nationwide. Content is verified and linked to the original source.
Items are compiled via live web search from real news outlets and trusted food-allergy sources, then stored in our database. Headlines and links point to the original articles or video pages — always verify details by reading the full source. This feed is for awareness only and is not medical advice.
A clinical trial led by Dr. Kari Nadeau aimed at preventing food allergies in 800 infants is at risk of termination due to federal research funding cuts, potentially endangering patient safety and progress in allergy prevention.
A wrongful death lawsuit has been filed against a grocer and a bakery following the death of a 25-year-old dancer who suffered a fatal anaphylactic reaction to a mislabeled cookie containing peanuts.
The FDA has approved an Investigational New Drug application for LongBio's next-generation anti-IgE antibody, LP-003, to begin clinical trials for the treatment of food allergies.
A nationwide clinical trial led by Stanford Medicine researchers demonstrated that children and young adults with multiple food allergies can safely consume full servings of foods they were previously allergic to following specific treatment protocols.
A mother and her son filed a complaint with the Department of Transportation after being removed from an Allegiant Air flight following a request for nut allergy accommodations.
Governor Josh Shapiro signed House Bill 928, making Pennsylvania the eighth state to enact Elijah's Law. The legislation mandates food allergy training and emergency preparedness in childcare settings.
Two new federal bills have been introduced to support those with Alpha-gal syndrome, including legislation that would require alpha-gal to be listed on food labels and increase federal funding for tick-borne disease research.
Recent research highlights a new antibody-based strategy aimed at retraining the immune system to tolerate food allergens. This approach offers potential hope for children who are too sensitive to traditional oral immunotherapy.
FARE criticized a Super Bowl commercial for Uber Eats that used a peanut allergy reaction as a punchline. Following public outcry from the allergy community, the company removed the specific depiction from the advertisement.
Governor Gavin Newsom signed California's Elijah's Law on September 25, 2024, requiring state agencies to create an anaphylaxis policy for childcare centers. The policy allows facilities to opt-in to training and epinephrine administration protocols.
Governor Josh Shapiro signed House Bill 928 into law, making Pennsylvania the eighth state to enact Elijah's Law, which mandates food allergy training and anaphylaxis protocols in childcare centers.
SnackSafely.com introduced a new service aimed at improving transparency regarding food allergens for consumers. The initiative focuses on providing clearer information about shared lines and facilities to help those with food allergies make safer choices.
Television personality Jo Frost shares her personal experience with anaphylaxis to raise awareness about the severity of food allergies. The article highlights the importance of preparedness and public education regarding life-threatening allergic reactions.
Following the FDA approval of lab-grown salmon, this article examines the implications for individuals with fish allergies. It discusses whether these products pose similar risks to traditional seafood and what labeling requirements apply.
Advocates are criticizing a proposed FAA rule that leaves uncertainty regarding the mandatory inclusion of epinephrine in airline emergency medical kits. The community is calling for the FAA to require epinephrine rather than suggesting it as an optional medication for anaphylaxis.
A clinical trial found that omalizumab (Xolair) was more effective and better tolerated than oral immunotherapy for treating multi-food allergies. Participants showed a higher ability to consume multiple allergens without reaction compared to those on OIT.
Long-term follow-up data from the LEAP-Trio study confirms that introducing peanut products in infancy provides lasting protection against peanut allergy through adolescence, regardless of how often peanut is consumed later in childhood.
The FDA approved omalizumab for the reduction of allergic reactions to accidental food exposure in adults and children aged 1 year and older. The approval was supported by data from the NIAID-funded OUtMATCH clinical trial.
This article reports on the expansion of Elijah's Law across the U.S., explicitly listing Illinois as one of the states that has already enacted this legislation to protect children in childcare centers.
A report by Nutritics indicates that the restaurant industry loses billions annually due to unclear or missing allergen information on menus. The study notes that a significant percentage of diners with food allergies avoid establishments that fail to provide transparent allergen disclosures.
The FDA announced a series of virtual public meetings to discuss the potential implementation of food allergen thresholds. These discussions are intended to help the agency establish standardized, science-based criteria for allergen labeling on food products.
New research from Japan indicates that cofactors, most notably exercise, are implicated in approximately 50 percent of severe food-induced anaphylaxis cases in adults. The study suggests that identifying these triggers is crucial for understanding why reactions vary in severity.
A nationwide clinical trial led by Stanford Medicine researchers found that omalizumab can help children and young adults with multiple food allergies safely consume foods they were previously allergic to. The study highlights that treatment goals vary by patient, offering multiple paths to living safely with food allergies.
A family has settled a lawsuit against a Florida school district following the death of a student who suffered a fatal allergic reaction after being served food containing nuts. The case highlights the critical importance of strictly following established food allergy management and prevention plans in schools.
Governor Kathy Hochul signed a law making New York the first state to mandate that health insurers eliminate cost-sharing requirements, such as deductibles and copays, for asthma inhalers. This policy aims to improve affordability and access to essential respiratory medication for state residents.
Southwest Airlines faced backlash from the food allergy community after announcing the introduction of pistachios as a snack in certain seating areas. Advocates expressed concern that this move compromises the safety of passengers with nut allergies.
New research from Japan indicates that cofactors, most notably exercise, are implicated in approximately 50 percent of severe food-induced anaphylaxis cases in adults. The study highlights how external factors can significantly worsen allergic reactions.
An 8-year-old boy in Ontario passed away following a severe allergic reaction to a frozen dairy treat. The tragedy has prompted renewed reminders for families and food servers to rigorously verify ingredients for those with life-threatening allergies.
A recent study indicates that while the eczema medication Dupixent (dupilumab) can lower IgE levels associated with food allergies, it may paradoxically increase the risk of allergic reactions in some patients.
Novartis has launched a Phase 3 clinical trial for the drug remibrutinib, a pill being tested for its ability to protect against allergic reactions to peanut, milk, and egg in teens and adults.
Disney World has introduced a dedicated food allergy ordering station at EPCOT to help guests with dietary restrictions navigate dining options more safely and efficiently. The station aims to reduce the stress of explaining allergies to staff by providing a specialized service point.
The FAA has released a proposed rule to modernize emergency medical kits on U.S. flights, but critics argue the move toward a flexible, performance-based standard fails to guarantee the presence of modern epinephrine administration devices.
DBV Technologies has submitted a biologics license application to the FDA for its Viaskin peanut allergy patch, intended for children ages 4 to 7. The patch delivers small amounts of peanut protein through the skin to gradually increase tolerance.
A study conducted in Italy found that Xolair (omalizumab) allowed a majority of children with food allergies to consume allergens without reaction. The findings align with U.S. research supported by the NIH regarding the drug's efficacy in desensitization.
Walt Disney World has implemented updates to its food allergy guidance specifically regarding tree nuts. The update aims to clarify safety protocols for families visiting the parks.
A new report provides updated, comprehensive recommendations for schools to manage food allergies, including staff training, stock epinephrine, and emergency protocols. The guidance was developed by FARE in collaboration with medical and disability rights experts.
After advocacy from the nonprofit FARE, Uber Eats agreed to edit a Super Bowl commercial that featured an insensitive depiction of a life-threatening peanut allergy.
This article discusses the momentum of Elijah's Law, which mandates food allergy policies in child care centers. It notes that similar legislation has been introduced or considered in several states, including Kansas.
Moonlight Therapeutics has received FDA clearance to begin clinical testing of MOON101, a treatment for peanut allergy. The trial is supported by a $3 million grant from the National Institute of Allergy and Infectious Diseases.
New York lawmakers passed legislation in June 2026 to mandate that childcare centers maintain stock epinephrine and provide staff training. This bill strengthens the state's original Elijah's Law, which was the first of its kind in the nation.
The FDA is considering a shift toward a threshold-based system for food allergen labeling, which would estimate doses at which 95 percent of allergic individuals are protected. Public comments on this potential regulatory change are open through May 19, 2026.
Pennsylvania lawmakers are advancing House Bill 77, which aims to improve restaurant safety for diners with food allergies. The bill would require establishments to provide written allergen notices and display awareness posters for staff.
A new microneedle patch device for peanut allergy has entered clinical trials with support from the NIAID. The device aims to provide a multi-food allergen treatment option for both children and adults.
The article examines proposed research initiatives regarding vaccines and food allergies, noting that the scientific community maintains skepticism toward claims linking the two.
The food allergy community is expressing concern over proposed FAA rules regarding emergency medical kits on airplanes. Advocates are pushing for mandatory epinephrine auto-injectors to be included in all kits to better manage anaphylaxis during flights.
A family has filed a lawsuit following the death of a teenager who suffered a fatal allergic reaction to an airline meal. The suit alleges deficiencies in crew training and a lack of comprehensive allergen labeling requirements for in-flight food.
Following the FDA's approval of Xolair for food allergies, pharmaceutical companies are now working on biosimilar versions. This development is expected to expand treatment options and potentially increase accessibility for patients.
New federal legislation, the Protecting Children with Food Allergies Act, mandates that school food service staff undergo specific food allergy training. The law aims to improve safety protocols and emergency response capabilities in schools nationwide.
A social media influencer passed away after suffering a severe allergic reaction at a promotional event. Reports indicate the food item consumed was allegedly misidentified as safe, highlighting the critical need for better ingredient transparency in food service.
Following the death of a student due to a food allergy, parents are advocating for stricter restaurant labeling requirements. The case underscores the ongoing challenges in ensuring consistent allergen communication in the food service industry.
This report highlights that California is in the minority of states that mandate, rather than just allow, the stocking of epinephrine in schools, and notes the state's adaptation to newer epinephrine delivery systems.
This report details the enactment of Elijah's Law in Maryland, which mandates that childcare facilities implement policies to protect children with severe food allergies. It highlights the advocacy efforts of Thomas Silvera and the push for similar legislation in other states.
A family is suing an airline following the death of a teenager who suffered a fatal allergic reaction to an in-flight meal. The lawsuit alleges deficiencies in crew training and a lack of adequate emergency medical procedures for passengers with food allergies.
A new sublingual immunotherapy (SLIT) tablet for peanut allergy has shown promise in Phase 2 trials by increasing patient tolerance. The treatment is now advancing to Phase 3 clinical trials to further evaluate its safety and efficacy.
A new clinical trial is testing a potential rival to Xolair that aims to provide protection against multiple food allergies with less frequent dosing. The study is enrolling patients to evaluate the drug's ability to prevent allergic reactions.
A comprehensive review of 190 studies involving 2.8 million children identified infant eczema, delayed introduction of allergenic foods, and early antibiotic use as key risk factors for developing food allergies.
Novartis halted a Phase 3 study of the biologic drug ligelizumab for peanut allergy to implement an optimized dosing regimen. The company stated the decision was not related to safety concerns and plans to restart the study.
Researchers at Imperial’s National Heart & Lung Institute have reported positive safety and tolerability results from a Phase 1 trial of a new peanut allergy vaccine using virus-like particle technology.
A global food safety body has established a new risk-based approach for precautionary allergen labeling (PAL). The goal is to make 'may contain' warnings more consistent and science-based for consumers worldwide.
Researchers have established Canada's first FPIES registry to better understand this non-IgE-mediated food allergy. The study provides insights into the condition's prevalence and the need for increased clinical awareness.
A New York City ordinance mandates that all city childcare centers and schools be equipped with stock epinephrine, serving as a model for statewide legislative efforts.
Novartis halted a Phase 3 study of the biologic drug ligelizumab for peanut allergy to implement an optimized dosing regimen. The company stated the decision was not related to safety concerns and plans to restart the study in late 2024.
SnackSafely warns the community about viral social media posts falsely claiming that a single-dose vaccine has been developed to permanently cure peanut allergies. These claims are fabricated and not supported by any legitimate medical research.
Researchers at Imperial’s National Heart & Lung Institute reported positive safety and tolerability results from a Phase 1 trial of a new peanut allergy vaccine using virus-like particle technology. The study was published in the Journal of Allergy and Clinical Immunology.
New York lawmakers passed legislation in June 2026 to strengthen Elijah's Law by requiring childcare centers to maintain a stock of epinephrine devices on-site. The bill awaits the governor's signature to mandate both the availability of the medication and staff training.
Research published in the journal Allergy suggests that exposure to dogs may help reduce food allergy risk in children by influencing immune system development. The study indicates that children with food sensitivities may experience a developmental lag in their immune response.
Palforzia, the first FDA-approved oral immunotherapy for peanut allergy, is set to be discontinued in July 2026. The article discusses alternative treatment options for patients, including emerging biologic therapies.
A study found that an existing FDA-approved asthma drug was effective in blocking life-threatening food allergy reactions in mice. This research highlights a potential new pathway for treating severe food allergies.
Governor Gavin Newsom signed California's Elijah's Law on September 25, 2024, requiring state agencies to create anaphylaxis policies for daycare centers. The law authorizes centers to implement training for recognizing and treating anaphylaxis and managing epinephrine auto-injectors.
A recent study explores Food Protein-Induced Enterocolitis Syndrome (FPIES), highlighting that many children can tolerate baked forms of trigger foods like egg and milk. The research also indicates that many children eventually outgrow this condition.
New federal legislation mandates that school food service personnel receive annual training on managing food allergies. The law aims to improve safety for the estimated six million children in the U.S. living with food allergies.
Mondelēz Global LLC issued a voluntary recall for belVita breakfast products due to undeclared peanut contamination caused by cross-contact on a manufacturing line. The incident highlights ongoing concerns regarding allergen labeling and manufacturing safety.
The Protecting Children with Food Allergies Act has been signed into law, requiring school food staff to undergo mandatory allergy training. Experts note this is critical as 20 percent of school epinephrine administrations involve children with undiagnosed allergies.
Walt Disney World is updating its menu tree nut definition to align with the FDA's revised guidance, which removes coconut, chestnut, hickory, and several other nuts from the major allergen list. Guests with allergies to those newly excluded items should read ingredient labels carefully, as items labeled 'tree nut free' will no longer exclude them.
IgGenix announced that Phase 1 clinical trials for its monoclonal antibody-based therapeutic candidate, IGNX001, are scheduled to begin in Australia. The treatment is designed to provide protection against allergen exposure more rapidly than traditional methods.
Moonlight Therapeutics has initiated a Phase I clinical trial, known as the SURVEYOR study, to evaluate the safety and tolerability of its MOON101 microneedle therapy for peanut allergy. This marks the program's transition from preclinical research to human clinical testing.
IgGenix presented data at the 2024 EAACI Annual Meeting regarding its monoclonal antibody-based therapeutic candidate for peanut allergy. The company utilized its proprietary antibody discovery platform to develop a treatment aimed at blocking the allergic cascade.
A fatality has been confirmed linked to Alpha-gal syndrome, a tick-borne condition that causes a severe allergic reaction to red meat. The report highlights the increasing public health concern regarding this allergy.
Virginia has introduced new legislation requiring restaurants to use specific identifying markers on takeout orders when a customer has communicated a food allergy or sensitivity. The law aims to improve communication and safety for diners with dietary restrictions.
Research indicates that baked milk oral immunotherapy is a safe and effective treatment for children with severe cow's milk allergies. The study suggests this method helps build tolerance in allergic patients.
New York enacted legislation requiring large public venues like stadiums and ballparks to stock epinephrine auto-injectors and have trained personnel on-site. This makes New York the first state to mandate such requirements for these types of public facilities.
The Girl Scouts have partnered with Partake to launch 'Sparkables,' an allergy-friendly and gluten-free cookie. The product is manufactured in a dedicated facility free of the top nine food allergens to ensure safety for consumers with dietary restrictions.
This summary reviews ten significant advancements in food allergy research from 2025, including new pathways for treating anaphylaxis and developments in managing acquired allergies.
A study presented at the 2026 AAAAI Annual Meeting reveals that over 75% of children with food allergies are allergic to multiple foods. The findings highlight the need for more comprehensive pediatric management strategies for multi-food allergic patients.
NIAID reports on recent scientific progress regarding alpha-gal syndrome, including the discovery of rare human antibodies that may block allergic reactions to red meat. The agency notes that millions of Americans are bitten by ticks annually, which remains the primary driver of this allergy.
This report highlights recent fatal anaphylactic reactions, including the death of influencer Dominique Brown, to emphasize the ongoing risks of food allergies. The article calls for increased vigilance and better allergen communication in public settings.
A study presented at the 2026 AAAAI Annual Meeting reveals that 75.5% of children with food allergies are allergic to multiple foods. The findings suggest that clinicians should anticipate additional allergies based on a child's existing diagnosis to improve management.
A lawsuit has been filed against Whole Foods following an incident where a child suffered an anaphylactic reaction after consuming pizza from the store. The case highlights ongoing concerns regarding food allergen labeling and safety protocols.
This article features a discussion on Tolerance Induction Program (TIP) therapy, which aims to help patients achieve complete remission from food allergies through a structured treatment protocol.
SnackSafely.com warns the community about the proliferation of misleading or fraudulent reports regarding purported cures for food allergies, emphasizing the importance of relying on verified medical information.
Governor Kathy Hochul signed legislation capping the cost of epinephrine auto-injectors at $100 per year for New York residents. The law aims to remove financial barriers for families managing life-threatening food allergies.
Delta Air Lines is introducing epinephrine auto-injectors into the emergency medical kits of all its aircraft over the next year, and Allegiant Air is also phasing in auto-injectors alongside its existing epinephrine vials. The voluntary safety upgrades come as the food allergy community urges the FAA to make epinephrine devices mandatory in airline medical kits before the October 5 public-comment deadline, with AAFA, FARE, the AMA, and Senators Duckworth and Schumer all pressing for a required modern epinephrine delivery device on every flight.
The Nadeau Lab provides updates on the SEAL study, which investigates the 'Atopic March' and the progression from eczema in infancy to other allergic conditions like food allergies.
Moonlight Therapeutics has received FDA clearance to begin clinical trials for MOON101, an intradermal allergen immunotherapy platform designed to desensitize individuals with peanut allergies.
Following the original Elijah's Law, new 2026 legislative amendments were passed to mandate that childcare centers maintain stock epinephrine, moving beyond the previous opt-in model.
A new peanut allergy therapy, PVX108, has received FDA Fast Track designation. The treatment is currently being evaluated in an international Phase 2 clinical trial involving children and adolescents.
New federal legislation has been signed into law aimed at enhancing protections for children living with food allergies. The bill focuses on improving safety standards and support systems for students in educational environments.
This article discusses the evolving landscape of food allergy treatments, specifically focusing on the introduction of biosimilars for Xolair, which is currently used to treat multiple food allergies.
The FDA has granted approval for clinical trials of a new anti-IgE antibody developed by LongBio, aimed at treating food allergies by targeting the underlying immune response.
While we strive for accuracy, information may change over time. Always double-check and verify against official sources before relying on it.
